Fas Ligand, soluble, Human (FASL) BioAssay(TM) ELISA Kit

The sFas Ligand ELISA is an enzyme-linked immunosorbent assay for quantitative detection of human sFas Ligand in solutions like supernatants and human body fluids. The sFas Ligand ELISA is for research use only. Not for use in diagnostic or therapeutic procedures.\n\nSensitivity: \n0.1ng/ml\n\nReproducibility:\nIntra-assay: 6.1%\nInter-assay: 7%\n\nSpike Recovery: ~85%\n\nKit Components:\nF0019-65G1: Microtiter Plate, 1x96 wells\nF0019-65G2: *sFas Ligand Mab (Biotin), 1x100ul \nF0019-65G3: *Standard, 2x1 vial \nF0019-65G4: Streptavidin (HRP), 1x150ul \nF0019-65G5: *Wash Buffer (20X), 1x50ml\nF0019-65G6: *Assay Buffer (20X), 1x5ml\nF0019-65G7: *Sample Diluent, 1x12ml\nF0019-65G8: Substrate I, 1x7ml\nF0019-65G9: Substrate II, 1x7ml\nF0019-65G10: Stop Solution 1M Phosphoric Acid, 1x15ml\nF0019-65G11: *Blue-Dye, 1x400ul \nF0019-65G12: *Green-Dye, 1x400ul \nF0019-65G13: *Red-Dye, 1x400ul\n\nNote:\n* Reagents contain 0.1% Proclin(R) 300 as preservative.\n\nStorage and Stability:\nStore components at 4 degrees C when not in use. Stable for at least 6 months. For maximum recovery of products, centrifuge the original vials prior to removing the cap.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

F0019-65G

Size

96Tests

Applications

ELISA

References

1. Das, H., et al., Br. J. Haematol. 104(4): 795-800 (1999). 2. De Maria, R. & Testi, R., Immunol. Today 19(3): 121-125 (1998). 3. Ertel, W., et al., J. Neuroimmunol. 80(1-2): 93-96 (1997). 4. Greil, R., et al., Leuk. Lymphoma 31(5-6): 477-490 (1998). 5. Hasegawa, D., et al., Blood 91(8): 2793-2799 (1998). 6. Hashimoto, H., et al., Arthritis Rheum. 41(4): 657-662 (1998). 7. Hori, Y., et al., Am. J. Hematol. 61(1): 21-25 (1999). 8. Hosaka, N., et al., J. Infect. Dis. 178(4): 1030-1039 (1998). 9. Jie-hui, L., et al., J. of Immunol. 161: 3943-3949 (1998). 10. Kanda, Y., et al., Leuk. Lymphoma 34(5-6): 625-628 (1999). 11. Kanda, Y., et al., Bone Marrow Transplant 22(8): 751-754 (1998). 12. Kato, K., et al., Br. J. Haematol. 103(4): 1164-1166 (1998). 13. Ken-ichiro, S., et al., J. of Immunol. 161: 4484-4488 (1998). 14. Hill, L.L., et al., Science 285: (1999). 15. Lee, S.H., et al., APMIS 06(11): 1035-1040 (1998). 16. Mann, B., et al., Br. J. Cancer 79(7-8): 1262-1269 (1999). 17. Matute-Bello, G., et al., J. Immunol. 163(4): 2217-2225 (1999). 18. Mitsiades, N., et al., Am. J. Pathol. 153(6): 1947-1956 (1998). 19. Murayama, T., et al., Am. J. Hematol. 62(4): 253-255 (1999). 20. Nakamoto, Y., et al., Oncol. Rep. 6(4): 733-739 (1999). 21. Nozawa, K., et al., Arthritis Rheum. 41(4): 657-662 (1998). 22. O